Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Bullboard Posts
Post by canadapieton Nov 26, 2019 11:13am
119 Views
Post# 30393456

terrible

terribleDown???!!!!!! Again !!!!!

Something teriibly wrong with TH !!! 

Management???
Salespeople???
Whole company???
Market sector???
Products???

Market was wrong at 8 and 7 and 6 and 5 and......., fill in for yourself. 
What a move to go to Nasdaq without anything, just to have a listing there...???
And insider buying???? With that amount = Laughable (saw that at "ASIT" also, now down 90%!!) .

@Wino :agree with you're assumptions for possible future price, IF they can grow patients, so for now no growth there = no better sales = no higher income = many costs coming = dollar outflow = 
........ they will do a "capital increase" and existing shareholders are again "mocked". 

I thought to buy again my shares if it ever would go down under 4 CAD,but now i'll wait for sure if they can ever sell more of their product!! 

Good luck all !! 

Bullboard Posts